open access

Vol 63, No 6 (2013)
Research paper (original)
Published online: 2013-12-12
Get Citation

Tubular breast cancer seen in the Oncology Centre in Kraków. Clinical characteristics and results of therapy of patients treated between 1955 and 2002

Beata Sas-Korczyńska, Jerzy Mituś, Andrzej Stelmach, Janusz Ryś, Elżbieta Włodarczyk
DOI: 10.5603/NJO.2013.0047
·
Nowotwory. Journal of Oncology 2013;63(6):443-448.

open access

Vol 63, No 6 (2013)
Original article
Published online: 2013-12-12

Abstract

Introduction. Tubular breast cancer accounts for approximately 1% to 2% of all invasive breast cancer types. It is composed of well-diff erentiated tubular structures which are lined by a single layer of epithelial cells. The purpose of this study is to present the clinical characteristics and treatment outcomes of 67 patients treated for tubular breast cancer at the Oncology Centre in Kraków between 1955 and 2002.

Material and methods. Stage I or II cancer was found in 62 patients (92.5%) of the total group. In 43 cases (64.2%)the size of the breast tumor was 2 cm or less. In 52 patients (77.6%) no axillary lymph node metastasis was observed.

Surgery was used as primary method of therapy in all patients. Mastectomy was performed in 60 patients and 7 patients underwent breast conserving surgery. Post-operative radiotherapy was received by 13 patients. Systemic treatment such as chemotherapy and hormonal therapy were also performed.

Results. The maximum follow-up period was 320 months. 10-year survivals were as follows: 83.8% (overall survival) and 91.6% (disease-free survival).

During the follow-up 2 patients (3%) developed local recurrence and in 5 patients (7.5%) distant metastases were observed. A second primary cancer was found in 8 patients (11.9%).

Conclusions. Outcomes confi rm good prognosis in patients treated with tubular breast cancer. There is possibility of early diagnosis and this will enable the provision of breast conserving treatment. This is a very important factor infl uencing quality of life in patients with breast cancer.

Abstract

Introduction. Tubular breast cancer accounts for approximately 1% to 2% of all invasive breast cancer types. It is composed of well-diff erentiated tubular structures which are lined by a single layer of epithelial cells. The purpose of this study is to present the clinical characteristics and treatment outcomes of 67 patients treated for tubular breast cancer at the Oncology Centre in Kraków between 1955 and 2002.

Material and methods. Stage I or II cancer was found in 62 patients (92.5%) of the total group. In 43 cases (64.2%)the size of the breast tumor was 2 cm or less. In 52 patients (77.6%) no axillary lymph node metastasis was observed.

Surgery was used as primary method of therapy in all patients. Mastectomy was performed in 60 patients and 7 patients underwent breast conserving surgery. Post-operative radiotherapy was received by 13 patients. Systemic treatment such as chemotherapy and hormonal therapy were also performed.

Results. The maximum follow-up period was 320 months. 10-year survivals were as follows: 83.8% (overall survival) and 91.6% (disease-free survival).

During the follow-up 2 patients (3%) developed local recurrence and in 5 patients (7.5%) distant metastases were observed. A second primary cancer was found in 8 patients (11.9%).

Conclusions. Outcomes confi rm good prognosis in patients treated with tubular breast cancer. There is possibility of early diagnosis and this will enable the provision of breast conserving treatment. This is a very important factor infl uencing quality of life in patients with breast cancer.

Get Citation
About this article
Title

Tubular breast cancer seen in the Oncology Centre in Kraków. Clinical characteristics and results of therapy of patients treated between 1955 and 2002

Journal

Nowotwory. Journal of Oncology

Issue

Vol 63, No 6 (2013)

Article type

Research paper (original)

Pages

443-448

Published online

2013-12-12

DOI

10.5603/NJO.2013.0047

Bibliographic record

Nowotwory. Journal of Oncology 2013;63(6):443-448.

Authors

Beata Sas-Korczyńska
Jerzy Mituś
Andrzej Stelmach
Janusz Ryś
Elżbieta Włodarczyk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl